English French German News Category AllIn the news - EnglishIn the news - FrenchIn the news - German Year All20262025 March 5, 2026 PME Oculis: la biotech suisse qui redonne la vue et séduit Wall Street March 4, 2026 Eyes On Eyecare Oculis’ DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema January 27, 2026 Finanz und Wirtschaft Oculis birgt ein potenzielles Pharma-Juwel January 12, 2026 Neurology Live Neuroprotective Agent Privosegtor Gains FDA Breakthrough Designation for Optic Neuritis January 8, 2026 Multiple Sclerosis News Privosegtor granted FDA breakthrough status for optic neuritis January 7, 2026 Healio FDA grants breakthrough therapy designation to privosegtor for optic neuritis January 6, 2026 Ophthalmology Times FDA grants breakthrough therapy designation to Oculis’ privosegtor for optic neuritis November 18, 2025 PharmaBoardroom Eyes on the Prize in a Booming Ophthalmology Market November 17, 2025 Swissquote Magazine « Le nombre de troubles oculaires augmente » November 17, 2025 Swissquote Magazine 8 companies to watch
